SCHEMBL15580705

SCHEMBL15580705

Bc1cnc(Nc2ccc(CCC(=O)NCCN(CC)CC)cc2)nc1Nc1cc(C2CC2)[nH]n1

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4456120 0.91 IGF1R (1.00) IGF1R
SCHEMBL4461050 0.87 IGF1R (1.00) IGF1R
SCHEMBL12653098 0.79 IGF1R (0.82) IGF1R
SCHEMBL4457637 0.79 IGF1R (1.00) IGF1R
SCHEMBL4455738 0.77 IGF1R (1.00) IGF1R
SCHEMBL14025723 0.77 IGF1R (1.00) IGF1R
SCHEMBL11341966 0.76 IGF1R (1.00) IGF1R
SCHEMBL4463246 0.75 IGF1R (0.77) IGF1R
SCHEMBL14050435 0.74 IGF1R (0.84) IGF1R
SCHEMBL4459218 0.73 IGF1R (0.85) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139484-B9 METHODS OF TREATING CANCER USING PYRIDOPYRIMIDINONE INHIBITORS OF PI3K ALPHA EXELIXIS INC (US) 2014-06-11 EP disclosed